call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Anti Hair Loss Medicine Market
Inquire Before Buying Request for Sample

Anti Hair Loss Medicine Market

Home Healthcare And Pharmaceutical Anti Hair Loss Medicine Market

Anti-Hair Loss Medicine Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Product, Medicine); By Gender (Male, Female); By End User (Dermatology Clinics, Hospitals, Home Care Setting); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: May 2023
  • Report ID: BWC23363
  • Available Format: PDF
  • Page: 400

Report Overview

Increasing prevalence of hair loss among the global population, growing availability of a wide range of hair loss treatments and products, and a spurring demand for personalized hair loss treatment solutions are projected to propel the expansion of the global anti-hair loss medicine market during the forecast period between 2023 and 2029.

Global Anti-Hair Loss Medicine Market - Industry Trends & Forecast Report, 2029

Global anti-hair loss medicine market size was estimated at USD 24.41 billion in 2022. During the forecast period between 2023 and 2029, the size of global anti-hair loss medicine market is projected to grow at a CAGR of 4.48% reaching a value of USD 32.93 billion by 2029. Major growth drivers for global anti-hair loss medicine market include increasing prevalence of hair loss or alopecia among the global population, growing aging population, changing lifestyles, and increasing awareness and acceptance of hair loss treatments. Alopecia can be caused by a range of factors, including genetics, hormonal imbalances, stress, and medical conditions, among others. As a result, there is a significant demand for effective treatments and solutions to help prevent or reverse hair loss. In recent years, there has been a growing trend towards the use of natural and herbal remedies for hair loss, such as herbal oils, shampoos, and supplements. Technological advancements have led to the development of innovative hair loss solutions, such as laser caps and helmets, scalp micropigmentation, and platelet-rich plasma therapy. Also, rising disposable incomes and the desire for improved aesthetics have led to greater demand for hair restoration products.

Global Anti-Hair Loss Medicine Market

Global Anti-Hair Loss Medicine Market – Overview

The anti-hair loss medicine market refers to the industry that involves the development, manufacturing, and marketing of pharmaceuticals and other treatments designed to prevent or reduce hair loss or alopecia. Hair loss has become a significant concern for many individuals in today's world due to various internal factors such as hormonal imbalances, major illnesses, aging, and others. The market for hair loss treatment products is growing rapidly as there is a rising demand for treatments for androgenetic alopecia, a hair problem that affects women, men, and children, leading to baldness and requiring medication. For instance, the American Academy of Dermatology reports that more than 40% of women globally experience hair loss issues by age 40 due to hormonal imbalances and other reasons. Additionally, increasing stress levels resulting from the ever-changing lifestyles have contributed significantly to the prevalence of hair loss. As the demand for hair loss treatment products continues to rise globally, manufacturers are introducing new and innovative products to address this concern. By targeting conscious consumers and revitalizing their product portfolios, manufacturers are aiming to attain a larger market share. As a result, the global anti-hair loss medicine market is expected to experience significant growth in the coming years.

Global Anti-Hair Loss Medicine Market

Growth Drivers

Increasing Prevalence of Hair Loss

The market for hair loss prevention products is being driven by the growing prevalence of hair loss among young individuals. According to the Mayo Foundation for Medical Education and Research (MFMER), hair loss can be caused by a variety of factors, including hereditary makeup that accelerates with aging, hormonal changes due to pregnancy, childbirth, menopause, and thyroid problems, side effects of certain medications and treatments, exposure to radiation during treatment or other conditions, stressful lifestyles causing hair thinning, and the use of chemical sprays during excessive hairstyling. To combat hair loss, people are continuously seeking effective hair care products, such as shampoos and conditioners, oils, and serums, to reduce hair loss and restore hair growth. The National Institute of Health (NIH) reports that long-term stress in the US can put people at risk of various health problems, including depression and anxiety, as well as digestion and sleep-related issues. The US Census data and Simmons National Consumer Survey (NHCS-2010 to 2020) estimated that consumers in the US spent approximately USD 65 on hair care products per year, and more than 12.4 million Americans had used hair regrowth products in 2020.

Restraints

Limited Efficacy of Some Hair Loss Medicines

The limited efficacy of certain hair loss medicines is anticipated to restrain the growth of the global anti-hair loss medicine market. While there are several effective hair loss treatment products available, some may not produce the desired results for all individuals. It can lead to dissatisfaction among users, causing them to search for alternative products or treatments. Additionally, some hair loss medicines may have side effects, which can deter individuals from using them. This can result in decreased demand for these products and a slowdown in the growth of the global anti-hair loss medicine market.

Impact of COVID-19 on Global Anti-Hair Loss Medicine Market

COVID-19 pandemic adversely affected the global anti-hair loss medicine market. The pandemic disrupted supply chains and caused significant economic slowdowns, leading to a decrease in demand for non-essential products, including hair loss treatment products. Lockdowns and social distancing measures also impacted the availability of hair loss treatment services, such as hair transplant surgeries and in-clinic treatments, which led to a shift towards home-based treatments and products. However, the pandemic also led to increased stress levels, which can exacerbate hair loss. It drove the demand for hair loss treatment products, particularly those that can be used at home.

Global Anti-Hair Loss Medicine Market

Segmental Coverage

Global Anti-Hair Loss Medicine Market – By Type

Based on type, the global anti-hair loss medicine market is bifurcated into Product and Medicine segments. The product segment holds a higher share in the global anti-hair loss medicine market. The product segment includes shampoo & conditioner, oil, and serum. Among them, the shampoo conditioner segment holds the highest market share, while the oils segment is expected to record the highest compound annual growth rate (CAGR) during the forecast period. The popularity of shampoos and conditioners is due to their widespread use, and the unisex segment was the most widely used. On the other hand, the men's segment is expected to have the highest CAGR during the forecast period, primarily driven by the increasing demand for hair loss prevention products among young men. While most manufacturers offer a range of unisex hair care products, such as shampoos, conditioners, oils, and serums, they are now revitalizing their product portfolios to target specific customers by introducing new products at affordable prices to gain a larger market share.

Anti-Hair Loss Medicine Market

Global Anti-Hair Loss Medicine Market – By Gender

Based on gender, global anti-hair loss medicine market is divided into Male and Female segments. The male segment is expected to hold a higher market share during the forecast period, due to an increasing demand for hair loss prevention products among men, particularly among the younger generation. Additionally, many manufacturers in the market are providing unisex hair care products like shampoos, conditioners, oils, and serums. However, these manufacturers are currently updating their product portfolios to cater to specific customers by introducing new products at reasonable prices to capture a larger market share.

Anti-Hair Loss Medicine Market Share

Global Anti-Hair Loss Medicine Market – By End User

Based on end user, the global anti-hair loss medicine market is segmented into Dermatology Clinics, Hospitals, and Home Care Setting. In 2022, the dermatology clinics segment held the highest market share, while the homecare settings segment is expected to grow during the forecast period. Hair loss is a common and significant issue that often leads to psychological distress and symptoms of depression. Whether temporary or long-lasting, severe hair loss has been driving the growth of the dermatology clinics segment in the market for hair loss treatment products, and this trend is expected to continue during the forecast period.

Anti-Hair Loss Medicine Market Size

Global Anti-Hair Loss Medicine Market – By Region

The in-depth research report on the global anti-hair loss medicine market covers various country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). The APAC region holds the highest share in the global anti-hair loss medicine market due to the presence of a large population suffering from hair loss issues, which has led to increased demand for hair loss treatment products in the region. The rising disposable income, increasing awareness about hair loss prevention and treatment, and the availability of a wide range of hair care products in the market have also contributed to the growth of the anti-hair loss medicine market in the APAC region. Also, the growth of e-commerce and online retail platforms has made it easier for consumers to access hair loss treatment products, further boosting the market growth.

Competitive Landscape

Major players operating in global anti-hair loss medicine market include Merck & Co., Inc., Johnson & Johnson, Dr. Reddy’s Laboratories Ltd., Cipla Inc., Sun Pharmaceutical Industries Ltd., Histogen Inc., Concert Pharmaceuticals, Inc., Aclaris Therapeutics, Inc., Follicum AB, Polichem S.A., Cassiopea SpA, PureTech Health, Kythera Biopharmaceuticals, Inc., Kerastem Technologies, and HairClone. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In November 2022 – Unilever, a global major consumer products company, announced the recall of its aerosol dry shampoo brands, including Dove. Those shampoo products were discovered that they had been contaminated with benzene that may cause cancer. The US FDA recall also covered brands including Nexxus, Suave, Tresemmé and Tigi.

  • In June 2022 - Eli Lilly and Company and Incyte announced that the US FDA granted marketing approval for Oluminant (baricitinib), a once-daily pill, as a first-in-disease systemic treatment for adults with severe alopecia areata (AA). AA is a disease that happens when the immune system attacks hair follicles and causes hair loss. Oluminant is available as 4-mg, 2-mg and 1-mg tablets.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Billion

Market Coverage

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Product/ Service Segmentation

Type, Gender, End Users, Region

Key Players

Merck & Co., Inc., Johnson & Johnson, Dr. Reddy’s Laboratories Ltd., Cipla Inc., Sun Pharmaceutical Industries Ltd., Histogen Inc., Concert Pharmaceuticals, Inc., Aclaris Therapeutics, Inc., Follicum AB, Polichem S.A., Cassiopea SpA, PureTech Health, Kythera Biopharmaceuticals, Inc., Kerastem Technologies, HairClone

 

By Type

  • Product

  • Medicine

By Gender

  • Male

  • Female

By End Users

  • Dermatology Clinic

  • Hospitals

  • Home Care Setting

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America

  • Middle East and Africa (MEA)

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global Anti-Hair Loss Medicine Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Increasing prevalence of hair loss among the global population
        2. Availability of a wide range of hair loss treatments and products
        3. Rising demand for personalized hair loss treatment solutions
      2. Restraints
        1. Limited efficacy of some hair loss medicines
        2. Social stigma associated with hair loss leading to a reluctance to seek treatment
      3. Opportunities
        1. Expansion of distribution channels and availability of hair loss medicines in emerging markets
        2. Increasing adoption of combination therapies for hair loss treatment
      4. Challenges
        1. Limited understanding of the underlying causes of hair loss
    3. Product Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global Anti-Hair Loss Medicine Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share and Forecast
      1. By Type
        1. Product
          1. shampoo & conditioner
          2. oil
          3. serum
          4. others
        2. Medicine
      2. By Gender
        1. Male
        2. Female
      3. By End Users
        1. Dermatology Clinic
        2. Hospitals
        3. Home Care Setting
        4. Others
      4. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  5. North America Anti-Hair Loss Medicine Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Gender
      3. By End Users
      4. By Country
        1. United States
          1. By Type
          2. By Gender
          3. By End Users
        2. Canada
          1. By Type
          2. By Gender
          3. By End Users
  6. Europe Anti-Hair Loss Medicine Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Gender
      3. By End Users
      4. By Country
        1. Germany
          1. By Type
          2. By Gender
          3. By End Users
        2. United Kingdom
          1. By Type
          2. By Gender
          3. By End Users
        3. Italy
          1. By Type
          2. By Gender
          3. By End Users
        4. France
          1. By Type
          2. By Gender
          3. By End Users
        5. Spain
          1. By Type
          2. By Gender
          3. By End Users
        6. Belgium
          1. By Type
          2. By Gender
          3. By End Users
        7. Russia
          1. By Type
          2. By Gender
          3. By End Users
        8. The Netherlands
          1. By Type
          2. By Gender
          3. By End Users
        9. Rest of Europe
          1. By Type
          2. By Gender
          3. By End Users
  7. Asia-Pacific Anti-Hair Loss Medicine Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Gender
      3. By End Users
      4. By Country
        1. China
          1. By Type
          2. By Gender
          3. By End Users
        2. India
          1. By Type
          2. By Gender
          3. By End Users
        3. Japan
          1. By Type
          2. By Gender
          3. By End Users
        4. South Korea
          1. By Type
          2. By Gender
          3. By End Users
        5. Australia & New Zealand
          1. By Type
          2. By Gender
          3. By End Users
        6. Indonesia
          1. By Type
          2. By Gender
          3. By End Users
        7. Malaysia
          1. By Type
          2. By Gender
          3. By End Users
        8. Singapore
          1. By Type
          2. By Gender
          3. By End Users
        9. Vietnam
          1. By Type
          2. By Gender
          3. By End Users
        10. Rest of APAC
          1. By Type
          2. By Gender
          3. By End Users
  8. Latin America Anti-Hair Loss Medicine Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Gender
      3. By End Users
      4. By Country
        1. Brazil
          1. By Type
          2. By Gender
          3. By End Users
        2. Mexico
          1. By Type
          2. By Gender
          3. By End Users
        3. Argentina
          1. By Type
          2. By Gender
          3. By End Users
        4. Peru
          1. By Type
          2. By Gender
          3. By End Users
        5. Rest of LATAM
          1. By Type
          2. By Gender
          3. By End Users
  9. Middle East & Africa Anti-Hair Loss Medicine Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Gender
      3. By End Users
      4. By Country
        1. Saudi Arabia
          1. By Type
          2. By Gender
          3. By End Users
        2. UAE
          1. By Type
          2. By Gender
          3. By End Users
        3. Qatar
          1. By Type
          2. By Gender
          3. By End Users
        4. Kuwait
          1. By Type
          2. By Gender
          3. By End Users
        5. South Africa
          1. By Type
          2. By Gender
          3. By End Users
        6. Nigeria
          1. By Type
          2. By Gender
          3. By End Users
        7. Algeria
          1. By Type
          2. By Gender
          3. By End Users
        8. Rest of MEA
          1. By Type
          2. By Gender
          3. By End Users
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Anti-Hair Loss Medicine Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Covid-19 on Global Anti-Hair Loss Medicine Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Merck & Co., Inc.
    2. Johnson & Johnson
    3. Dr. Reddy’s Laboratories Ltd.
    4. Cipla Inc.
    5. Sun Pharmaceutical Industries Ltd.
    6. Histogen Inc.
    7. Concert Pharmaceuticals, Inc.
    8. Aclaris Therapeutics, Inc.
    9. Follicum AB
    10. Polichem S.A.
    11. Cassiopea SpA
    12. PureTech Health
    13. Kythera Biopharmaceuticals, Inc.
    14. Kerastem Technologies
    15. HairClone
    16. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1.  Qualitative Research
      1.  Primary & Secondary Research
    2.  Quantitative Research
    3.  Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.  Breakdown of Primary Research Respondents, By Region
    5.  Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

 

List of Figures

Figure 1       Global Anti-Hair Loss Medicine Market Segmentation

Figure 2       Global Anti-Hair Loss Medicine Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2022

Figure 4       Global Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 5       Global Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 6       Global Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 7       Global Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 8       Global Anti-Hair Loss Medicine Market Share, By Region, By Value, 2019–2029

Figure 9       North America Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 10     North America Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 11     North America Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 12     North America Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 13     North America Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Figure 14     United States Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 15     United States Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 16     United States Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 17     United States Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 18     Canada Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 19     Canada Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 20     Canada Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 21     Canada Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 22     Europe Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 23     Europe Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 24     Europe Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 25     Europe Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 26     Europe Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Figure 27     Germany Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 28     Germany Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 29     Germany Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 30     Germany Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 31     United Kingdom Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 32     United Kingdom Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 33     United Kingdom Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 34     United Kingdom Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 35     Italy Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 36     Italy Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 37     Italy Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 38     Italy Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 39     France Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 40     France Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 41     France Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 42     France Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 43     Spain Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 44     Spain Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 45     Spain Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 46     Spain Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 47     Belgium Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 48     Belgium Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 49     Belgium Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 50     Belgium Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 51     Russia Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 52     Russia Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 53     Russia Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 54     Russia Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 55     The Netherlands Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 56     The Netherlands Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 57     The Netherlands Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 58     The Netherlands Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 59     Rest of Europe Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 60     Rest of Europe Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 61     Rest of Europe Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 62     Rest of Europe Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 63     Asia-Pacific Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 64     Asia-Pacific Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 65     Asia-Pacific Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 66     Asia-Pacific Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 67     Asia-Pacific Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Figure 68     China Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 69     China Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 70     China Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 71     China Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 72     India Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 73     India Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 74     India Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 75     India Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 76     Japan Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 77     Japan Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 78     Japan Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 79     Japan Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 80     South Korea Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 81     South Korea Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 82     South Korea Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 83     South Korea Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 84     Australia & New Zealand Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 85     Australia & New Zealand Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 86     Australia & New Zealand Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 87     Australia & New Zealand Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 88     Indonesia Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 89     Indonesia Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 90     Indonesia Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 91     Indonesia Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 92     Malaysia Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 93     Malaysia Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 94     Malaysia Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 95     Malaysia Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 96     Singapore Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 97     Singapore Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 98     Singapore Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 99     Singapore Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 100   Vietnam Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 101   Vietnam Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 102   Vietnam Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 103   Vietnam Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 104   Rest of APAC Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 105   Rest of APAC Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 106   Rest of APAC Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 107   Rest of APAC Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 108   Latin America Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 109   Latin America Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 110   Latin America Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 111   Latin America Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 112   Latin America Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Figure 113   Brazil Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 114   Brazil Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 115   Brazil Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 116   Brazil Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 117   Mexico Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 118   Mexico Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 119   Mexico Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 120   Mexico Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 121   Argentina Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 122   Argentina Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 123   Argentina Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 124   Argentina Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 125   Peru Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 126   Peru Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 127   Peru Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 128   Peru Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 129   Rest of LATAM Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 130   Rest of LATAM Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 131   Rest of LATAM Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 132   Rest of LATAM Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 133   Middle East & Africa Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 134   Middle East & Africa Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 135   Middle East & Africa Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 136   Middle East & Africa Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 137   Middle East & Africa Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Figure 138   Saudi Arabia Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 139   Saudi Arabia Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 140   Saudi Arabia Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 141   Saudi Arabia Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 142   UAE Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 143   UAE Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 144   UAE Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 145   UAE Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 146   Qatar Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 147   Qatar Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 148   Qatar Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 149   Qatar Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 150   Kuwait Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 151   Kuwait Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 152   Kuwait Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 153   Kuwait Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 154   South Africa Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 155   South Africa Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 156   South Africa Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 157   South Africa Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 158   Nigeria Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 159   Nigeria Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 160   Nigeria Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 161   Nigeria Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 162   Algeria Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 163   Algeria Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 164   Algeria Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 165   Algeria Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Figure 166   Rest of MEA Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Figure 167   Rest of MEA Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Figure 168   Rest of MEA Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Figure 169   Rest of MEA Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

 

List of Tables

Table 1 Global Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 2 Global Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 3 Global Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 4 Global Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 5 Global Anti-Hair Loss Medicine Market Share, By Region, By Value, 2019–2029

Table 6 North America Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 7 North America Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 8 North America Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 9 North America Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 10      North America Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Table 11      United States Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 12      United States Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 13      United States Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 14      United States Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 15      Canada Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 16      Canada Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 17      Canada Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 18      Canada Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 19      Europe Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 20      Europe Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 21      Europe Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 22      Europe Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 23      Europe Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Table 24      Germany Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 25      Germany Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 26      Germany Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 27      Germany Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 28      United Kingdom Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 29      United Kingdom Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 30      United Kingdom Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 31      United Kingdom Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 32      Italy Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 33      Italy Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 34      Italy Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 35      Italy Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 36      France Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 37      France Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 38      France Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 39      France Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 40      Spain Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 41      Spain Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 42      Spain Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 43      Spain Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 44      Belgium Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 45      Belgium Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 46      Belgium Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 47      Belgium Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 48      Russia Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 49      Russia Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 50      Russia Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 51      Russia Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 52      The Netherlands Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 53      The Netherlands Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 54      The Netherlands Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 55      The Netherlands Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 56      Rest of Europe Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 57      Rest of Europe Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 58      Rest of Europe Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 59      Rest of Europe Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 60      Asia-Pacific Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 61      Asia-Pacific Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 62      Asia-Pacific Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 63      Asia-Pacific Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 64      Asia-Pacific Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Table 65      China Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 66      China Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 67      China Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 68      China Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 69      India Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 70      India Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 71      India Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 72      India Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 73      Japan Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 74      Japan Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 75      Japan Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 76      Japan Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 77      South Korea Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 78      South Korea Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 79      South Korea Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 80      South Korea Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 81      Australia & New Zealand Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 82      Australia & New Zealand Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 83      Australia & New Zealand Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 84      Australia & New Zealand Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 85      Indonesia Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 86      Indonesia Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 87      Indonesia Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 88      Indonesia Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 89      Malaysia Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 90      Malaysia Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 91      Malaysia Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 92      Malaysia Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 93      Singapore Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 94      Singapore Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 95      Singapore Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 96      Singapore Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 97      Vietnam Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 98      Vietnam Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 99      Vietnam Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 100    Vietnam Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 101    Rest of APAC Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 102    Rest of APAC Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 103    Rest of APAC Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 104    Rest of APAC Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 105    Latin America Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 106    Latin America Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 107    Latin America Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 108    Latin America Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 109    Latin America Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Table 110    Brazil Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 111    Brazil Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 112    Brazil Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 113    Brazil Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 114    Mexico Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 115    Mexico Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 116    Mexico Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 117    Mexico Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 118    Argentina Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 119    Argentina Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 120    Argentina Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 121    Argentina Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 122    Peru Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 123    Peru Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 124    Peru Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 125    Peru Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 126    Rest of LATAM Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 127    Rest of LATAM Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 128    Rest of LATAM Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 129    Rest of LATAM Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 130    Middle East & Africa Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 131    Middle East & Africa Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 132    Middle East & Africa Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 133    Middle East & Africa Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 134    Middle East & Africa Anti-Hair Loss Medicine Market Share, By Country, By Value, 2019–2029

Table 135    Saudi Arabia Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 136    Saudi Arabia Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 137    Saudi Arabia Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 138    Saudi Arabia Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 139    UAE Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 140    UAE Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 141    UAE Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 142    UAE Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 143    Qatar Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 144    Qatar Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 145    Qatar Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 146    Qatar Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 147    Kuwait Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 148    Kuwait Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 149    Kuwait Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 150    Kuwait Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 151    South Africa Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 152    South Africa Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 153    South Africa Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 154    South Africa Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 155    Nigeria Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 156    Nigeria Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 157    Nigeria Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 158    Nigeria Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 159    Algeria Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 160    Algeria Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 161    Algeria Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 162    Algeria Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 163    Rest of MEA Anti-Hair Loss Medicine Market Size, By Value (USD Billion), 2019–2029

Table 164    Rest of MEA Anti-Hair Loss Medicine Market Share, By Type, By Value, 2019–2029

Table 165    Rest of MEA Anti-Hair Loss Medicine Market Share, By Gender, By Value, 2019–2029

Table 166    Rest of MEA Anti-Hair Loss Medicine Market Share, By End Users, By Value, 2019–2029

Table 167    Merck & Co., Inc.   Company Overview

Table 168    Merck & Co., Inc.   Financial Overview

Table 169    Johnson & Johnson Company Overview

Table 170    Johnson & Johnson Financial Overview

Table 171    Dr. Reddy’s Laboratories Ltd.     Company Overview

Table 172    Dr. Reddy’s Laboratories Ltd.     Financial Overview

Table 173    Cipla Inc.     Company Overview

Table 174    Cipla Inc.     Financial Overview

Table 175    Sun Pharmaceutical Industries Ltd.      Company Overview

Table 176    Sun Pharmaceutical Industries Ltd.      Financial Overview

Table 177    Histogen Inc.         Company Overview

Table 178    Histogen Inc.         Financial Overview

Table 179    Concert Pharmaceuticals, Inc.    Company Overview

Table 180    Concert Pharmaceuticals, Inc.    Financial Overview

Table 181    Aclaris Therapeutics, Inc. Company Overview

Table 182    Aclaris Therapeutics, Inc. Financial Overview

Table 183    Follicum AB  Company Overview

Table 184    Follicum AB  Financial Overview

Table 185    Polichem S.A.         Company Overview

Table 186    Polichem S.A.         Financial Overview

Table 187    Cassiopea SpA       Company Overview

Table 188    Cassiopea SpA       Financial Overview

Table 189    PureTech Health    Company Overview

Table 190    PureTech Health    Financial Overview

Table 191    Kythera Biopharmaceuticals, Inc.        Company Overview

Table 192    Kythera Biopharmaceuticals, Inc.        Financial Overview

Table 193    Kerastem Technologies    Company Overview

Table 194    Kerastem Technologies    Financial Overview

Table 195    HairClone     Company Overview

Table 196    HairClone     Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Note: Please share the corporate email address for faster response

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Major factors driving the growth of Global Anti-Hair Loss Medicine Market include increasing prevalence of hair loss among the global population, growing availability of a wide range of hair loss treatments and products, and rising demand for personalized hair loss treatment solutions.
Ans: Global Anti-Hair Loss Medicine Market size was estimated at USD 24.41 billion in 2022.
Ans: The product segment is expected to hold a higher market share in the Global Anti-Hair Loss Medicine Market by type.
Ans: The male segment is expected to hold a higher market share in the Global Anti-Hair Loss Medicine Market by gender.
Ans: Key players in Global Anti-Hair Loss Medicine Market include Merck & Co., Inc., Johnson & Johnson, Dr. Reddy’s Laboratories Ltd., Cipla Inc., Sun Pharmaceutical Industries Ltd., Histogen Inc., Concert Pharmaceuticals, Inc., Aclaris Therapeutics, Inc., Follicum AB, Polichem S.A., Cassiopea SpA, PureTech Health, Kythera Biopharmaceuticals, Inc., Kerastem Technologies, and HairClone. 
array(1) {
  ["__ci_last_regenerate"]=>
  int(1732236244)
}